MIAMI, Sept. 12, 2017 -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, re-opened its doors on Tuesday, September 12, 2017.
PharmCo, LLC did not sustain any damage during Hurricane Irma. Power was quickly restored in the area and the pharmacy opened its doors for business at its regularly scheduled time on Tuesday, September 12, 2017. The Company’s staff has been working today to reach as many people as possible to see if they need medication replacement or emergency supplies.
“We are extremely fortunate to have escaped the destructive effects of the hurricane,” stated S. Parikh Mars, CEO. “Today, as we assist those in need, we want to remind our patients to look at their medication needs and reach out for additional supplies and replacement. Patients, especially insulin dependent diabetics, should make sure not to take medication that has not been stored at the proper temperature due to loss of power. As always, the important thing is that everyone is safe. We feel blessed to know that all of our team members and their families are accounted for and well.”
About Progressive Care
Progressive Care, Inc. (OTC PINK:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Apple Turns 50: From Garage Startup to AI Crossroads
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
First Western Ship Transits Strait of Hormuz Since Iran War Began
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 



